Search
- Another Daily Reversal : Take More Off in Biotech February 21, 2012
- Gilead (GILD $46.50) off 15% on Hep-C Clinical Data -Viral Relapse Seen February 17, 2012
- No Panic Just Take A Little Off:Caution- Update Rally 2/16 February 15, 2012
- Rayno Life Science Portfolio Racks-Up More Gains: REGN, RGDX, SRLS February 13, 2012
- Response Genetics Raises $7.5M at $1.50 with New CEO February 2, 2012
- Rayno Life Science Tools And Dx Portfolio Update:Immucor Beats 6/20 update April 6, 2011
- Three Small Cap Stocks for a Rebound in January: AMRI,ASTX,SRLS-UPDATE 1/5/12 December 14, 2011
- Another Big Rally on Europe Non-News: Biotech Sector Lagging October 18, 2011
- Rayno 2009 Biotechnology Portfolio-Mid Year Update July 13, 2009
- JPMorgan Healthcare Conference-2010 Day One-Monday January 11 January 12, 2010
AACC
AACC Effect
AACR
active cellular immunotherapy
ADC antibody-drug conjugates
Add new tag
Alzheimer Disease
antibiotics
antibody-drug conjugates
antisense
antiviral
ASCO
B2-microglobulin
BATTLE Trial
bearish nat gas market
biodiscovery
BIO ETF's
biogenerics
BIOgraph
biomarkers
biomedical
biosimilars
Biotech ETF's
biotechnology sector
biotech portfolios and ETFs
biotech stocks
blood transfusion demand
BLUD
BMY
C.difficile
cancer vaccines immunotherapy
clinical diagnostics
companion diagnostics
diagnostics
genomics
genomics personalized medicine
genzyme
GILD
healthcare reform
life science ETF's
mass spec
molecular diagnostics
personalized medicine
pharmacogenomics
targeted therapy
